| Literature DB >> 27004739 |
Ran Wei1,2, Wei Dong1, Hongchang Shen3, Yang Ni3, Tiehong Zhang3, Yibing Wang4, Jiajun Du1,2.
Abstract
Pulmonary function tests had prospective implications for postoperative pneumonia, which occurred frequently after esophagectomy. Understanding factors that were associated with pulmonary infection may help in patient selection and postoperative management. We performed a retrospective review of 2 independent cohorts including 216 patients who underwent esophagectomy between November 2011 and May 2014, aiming at identifying predictors of primary pneumonia. Univariate analysis was used to identify potential covariates for the development of primary pneumonia. Adjustments for multiple comparisons were made using False Discovery Rate (FDR) (Holm-Bonferroni method). Multivariable logistic regression analysis was used to identify independent predictors and construct a regression model based on a training cohort (n = 166) and then the regression model was validated using an independent cohort (n = 50). It showed that low PEF (hazard ratio 0.97, P = 0.009) was independent risk factors for the development of primary pneumonia in multivariate analyses and had a predictive effect for primary pneumonia (AUC = 0.691 and 0.851 for training and validation data set, respectively). Therefore, PEF has clinical value in predicting postoperative pneumonia after esophagectomy and it may serve as an indicator of preoperative lung function training.Entities:
Mesh:
Year: 2016 PMID: 27004739 PMCID: PMC4804297 DOI: 10.1038/srep23636
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Baseline patient characteristics and preoperative risk factors for patients undergoing esophagectomy.
| Viariable | All patients N = 166 | Group I N = 149 | Group II N = 17 | |
|---|---|---|---|---|
| Age | 60.77 ± 7.66 | 60.97 ± 7.61 | 58.94 ± 8.01 | 0.30 |
| Male | 131(78.92%) | 116(77.85%) | 15(88.24%) | 0.53 |
| Body mass index (kg/m2) | 22.95 ± 3.24 | 22.98 ± 3.34 | 22.61 ± 2.24 | 0.54 |
| Medical history, n (%) | ||||
| Hypertension | 41(24.70%) | 36(24.16%) | 5(29.41%) | 0.77 |
| Diabetes mellitus | 16(9.64%) | 15(10.07%) | 1(5.88%) | 1.00 |
| Respiratory | 69(41.57%) | 61(40.94%) | 8(47.06%) | 0.80 |
| Heart disease | 26(15.66%) | 20(13.42%) | 6(35.29%) | 0.03 |
| Gastrointestinal ulcer | 124(75.90%) | 110(73.83%) | 14(82.35%) | 0.57 |
| Cerebrovescular disease | 4(2.41%) | 3(2.01%) | 1(5.88%) | 0.35 |
| Major surgery | 13(7.83%) | 12(8.05%) | 1(5.88%) | 1.00 |
| Duration of presenting symptoms(months) | 3.66 ± 7.83 | 3.36 ± 7.25 | 6.28 ± 11.71 | 0.33 |
| Time between diagnosis and surgery (days) | 6.80 ± 3.17 | 6.65 ± 2.69 | 8.12 ± 5.89 | 0.32 |
| Weight loss (kg) | 1.95 ± 2.74 | 2.08 ± 2.83 | 0.77 ± 1.30 | 0.002 |
| Albumin(g/L) | 41.49 ± 2.90 | 41.36 ± 2.93 | 42.62 ± 2.36 | 0.09 |
| Lymphocyte number≥1500( /mm | 107(64.46%) | 97(65.10%) | 10(58.82%) | 0.60 |
| Hemoglobin(mg/dL) | 141.43 ± 12.75 | 140.71 ± 12.80 | 147.65 ± 10.75 | 0.03 |
| Smoking history (ever-smokers) | 92(55.42%) | 82(55.03%) | 10(58.82%) | 1.00 |
| Tumor localization, n (%) | 0.11 | |||
| Upper | 15(9.04%) | 11(7.38%) | 4(23.53%) | |
| Middle | 57(34.34%) | 52(34.90%) | 5(29.41%) | |
| Lower | 94(56.62%) | 86(57.72%) | 8(47.06%) | |
| Pulmonary function test | ||||
| VC | 93.79 ± 16.57 | 94.66 ± 16.73 | 87.54 ± 13.12 | 0.09 |
| FVC | 89.86 ± 15.30 | 90.71 ± 15.07 | 83.39 ± 15.52 | 0.06 |
| FEV1 | 95.79 ± 18.31 | 97.09 ± 17.94 | 86.18 ± 18.61 | 0.02 |
| MVV | 87.91 ± 19.65 | 88.67 ± 18.96 | 79.60 ± 24.09 | 0.07 |
| PEF | 88.81 ± 21.25 | 90.18 ± 20.74 | 75.67 ± 22.91 | 0.008 |
| DLCO | 82.46 ± 15.61 | 82.29 ± 15.73 | 84.41 ± 15.70 | 0.59 |
adata are shown as mean ± standard deviation or n (%) as appropriate. VC: vital capacity; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 second; MVV: maximum ventilator volume; PEF: peak expiratory flow; DLCO: diffusing capacity for carbon monoxide.
Operative risk factors for patients undergoing esophagectomy.
| Viariables | All-patients N = 166 | Group I N = 149 | Group II N = 17 | |
|---|---|---|---|---|
| Type of esophagectomy, n (%) | 0.44 | |||
| Sweet | 94(56.63%) | 85(57.05%) | 9(52.94%) | |
| Ivor-Lewis | 42(25.30%) | 39(26.17%) | 3(17.65%) | |
| Mckeown | 30(18.07%) | 25(16.78%) | 5(29.41%) | |
| Site of anastomosis | 0.33 | |||
| Neck | 39(23.49%) | 27(18.12%) | 12(70.59%) | |
| Chest | 127(76.51%) | 122(81.88%) | 5(29.41%) | |
| Route of reconstruction | 0.80 | |||
| Retrosternal | 94(56.63%) | 85(57.05%) | 9(52.94%) | |
| Orthotopic | 72(43.37%) | 64(42.95%) | 8(47.06%) | |
| Thoracic duct ligation | 45(27.11%) | 38(25.50%) | 7(41.18%) | 0.25 |
| Blood loss (ml) | 249.82 ± 165.60 | 247.11 ± 162.65 | 276.67 ± 187.91 | 0.51 |
| Intraoperative blood transfusion (ml) | 60.54 ± 119.06 | 58.72 ± 117.08 | 76.47 ± 138.20 | 0.56 |
| Intraoperative erythrocyte transfusion (U) | 0.54 ± 1.13 | 0.51 ± 1.10 | 0.82 ± 1.42 | 0.26 |
| Vital volum/weight (L/kg) | 7.24 ± 1.24 | 7.21 ± 1.27 | 7.47 ± 0.97 | 0.44 |
| Length of anesthesia (min) | 277.14 ± 89.76 | 274.70 ± 88.95 | 298.53 ± 96.69 | 0.30 |
| Length of operation (min) | 240.24 ± 86.42 | 237.55 ± 84.76 | 263.82 ± 99.55 | 0.24 |
| Tumor length (cm) | 4.79 ± 2.07 | 4.81 ± 2.08 | 4.65 ±± 2.03 | 0.76 |
| American society of Anesthesiologist(ASA) score | 0.11 | |||
| I | 14(8.43%) | 14(9.40%) | 0(0.00%) | |
| II | 139(83.74%) | 125(83.89%) | 14(82.35%) | |
| III | 13(7.83%) | 10(6.71%) | 3(17.65%) | |
| T | 0.72 | |||
| Tis | 5(3.01) | 5(3.36%) | 0(0.00%) | |
| T1 | 10(6.02%) | 9(6.04%) | 1(5.88%) | |
| T2 | 27(16.27%) | 25(16.78%) | 2(11.77%) | |
| T3 | 120(72.29%) | 107(71.81%) | 13(76.47%) | |
| T4 | 4(2.41%) | 3(2.01%) | 1(2.13%) | |
| N | 0.46 | |||
| N0 | 87(52.41%) | 79(53.02%) | 8(47.06%) | |
| N1 | 38(22.89%) | 32(21.48%) | 6(3.53%) | |
| N2 | 28(16.87%) | 25(16.78%) | 3(17.65%) | |
| N3 | 13(7.83%) | 13(8.72%) | 0(0.00%) | |
| Stage | 0.88 | |||
| 0 | 5(3.01%) | 5(3.36%) | 0(0.00%) | |
| I | 9(5.42%) | 8(5.37%) | 1(5.88%) | |
| II | 78(46.99%) | 71(47.65%) | 7(41.18%) | |
| III | 74(44.58%) | 65(43.62%) | 9(52.94%) |
adata are shown as mean ± standard deviation or n(%) as appropriate.
Postoperative data of patients undergoing esophagectomy.
| Viariable | All patients N = 166 | Group I N = 149 | Group II N = 17 | |
|---|---|---|---|---|
| Blood transfusion (ml) | 231.52 ± 362.80 | 230.41 ± 373.88 | 241.18 ± 254.48 | 0.91 |
| Erythrocyte transfusion (U) | 0.49 ± 1.13 | 0.44 ± 1.03 | 0.94 ± 1.75 | 0.26 |
| ICU (days) | 0.31 ± 1.67 | 0.27 ± 1.61 | 0.71 ± 2.17 | 0.31 |
| Duration of respirator use (days) | 0.13 ± 0.68 | 0.07 ± 0.26 | 0.65 ± 1.94 | 0.24 |
| Oxygen inhalation (days) | 9.17 ± 8.32 | 9.19 ± 8.64 | 9.06 ± 4.87 | 0.95 |
| Analgesic (days) | 5.36 ± 2.39 | 5.39 ± 2.44 | 5.12 ± 1.93 | 0.66 |
| Length of stay (days) | 27.28 ± 18.10 | 26.38 ± 16.75 | 35.18 ± 26.64 | 0.20 |
| Antibiotics (days) | 5.11 ± 5.01 | 4.83 ± 4.84 | 7.53 ± 5.94 | 0.04 |
adata are shown as mean ± standard deviation or n(%) as appropriate.
Multivariate analysis of primary pneumonia.
| Risk Factors | Univariate Analysis (p value) | Multivariate Analysis (p value) | Hazard Ratio (95% confidence range) |
|---|---|---|---|
| PEF | 0.008 | 0.009 | 0.97(0.94−0.99) |
| Weight loss | 0.002 | 0.10 |
PEF: peak expiratory flow.
Figure 1Receiver operating characteristic curve analysis for primary pneumonia after esophagectomy.
Area under the curve (AUC) estimation for the peak expiratory flow (PEF) in (a) the training set, (b) the validation set.